Events8th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2022-13250 (registering DOI)
This submission belongs to the session S8. Pharmaceutical development of the event 8th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2022
Academic Editor
author-avatarAlfredo Berzal-Herranz
Citation
Samixa Rameshbhai Patel, Mital Niraj Manvar, Implementation of Qbd Approach to Develop and Validate HPTLC Method for simultaneous estimation of Aliskiren, Amlodipine and Hydrochlorothiazide in Pharmaceutical Formulation, in Proceedings of 8th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2022, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2022-13250
Share
Email
FaceBook
Twitter
Linkedin

Implementation of Qbd Approach to Develop and Validate HPTLC Method for simultaneous estimation of Aliskiren, Amlodipine and Hydrochlorothiazide in Pharmaceutical Formulation

1. School of pharmaceutical sciences, Atmiya University, ”Yogidham Gurukul”, Kalawad road, Raj-kot-360005.Gujrat, India.; samixa.patel@atmiyauni.ac.in
2. School of pharmaceutical sciences, Atmiya University, ”Yogidham Gurukul”, Kalawad road, Raj-kot-360005.Gujrat, India.
Abstract
Keywords
Aliskiren
Amlodipine besylate
Hydrochlorthiazide
high performance thin layer chromatography (HPTLC) method
Validation
Central Composite Design.)
Poster
sciforum-065951.pdf